← FDA Drug Approvals (Drugs@FDA)
BENZONATATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL RX · Approved 2018-11-09
Drug application
- FDA Application #
ANDA210562
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BENZONATATE
- Generic name
- Benzonatate
- Active ingredients
- BENZONATATE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- CHARTWELL RX
- First approval
- 2018-11-09
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown